User profiles for "author:Basel Karo"
 | Basel Karo, PhD, MPHCentre for International Health Protection (ZIG), Robert Koch Institute (RKI) Verified email at rki.de Cited by 505 |
[HTML][HTML] Drivers of airborne human-to-human pathogen transmission
S Herfst, M Böhringer, B Karo, P Lawrence… - Current opinion in …, 2017 - Elsevier
Highlights•Chain of pathogen transmission between individual donor and recipient is
modeled.•Related pairs of efficient and inefficient 'airborne'pathogens are …
modeled.•Related pairs of efficient and inefficient 'airborne'pathogens are …
[HTML][HTML] World health organization early warning, alert and response system in the Rohingya crisis, Bangladesh, 2017–2018
Abstract The Early Warning, Alert and Response System (EWARS) is a web-based system
and mobile application for outbreak detection and response in emergency settings. EWARS …
and mobile application for outbreak detection and response in emergency settings. EWARS …
[HTML][HTML] Epidemiological, clinical, and public health response characteristics of a large outbreak of diphtheria among the Rohingya population in Cox's Bazar …
JA Polonsky, M Ivey, MKA Mazhar, Z Rahman… - PLoS …, 2021 - journals.plos.org
Background Unrest in Myanmar in August 2017 resulted in the movement of over 700,000
Rohingya refugees to overcrowded camps in Cox's Bazar, Bangladesh. A large outbreak of …
Rohingya refugees to overcrowded camps in Cox's Bazar, Bangladesh. A large outbreak of …
[HTML][HTML] Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014
B Karo, A Kohlenberg, V Hollo, R Duarte… - …, 2019 - eurosurveillance.org
Introduction: Isoniazid (INH) is an essential drug for tuberculosis (TB) treatment. Resistance
to INH may increase the likelihood of negative treatment outcome. Aim: We aimed to …
to INH may increase the likelihood of negative treatment outcome. Aim: We aimed to …
Impact of HIV infection on treatment outcome of tuberculosis in Europe
Background: The effect of HIV on tuberculosis (TB) treatment outcomes has not been well
established. We aimed to assess the impact of HIV infection on TB treatment outcomes by …
established. We aimed to assess the impact of HIV infection on TB treatment outcomes by …
[HTML][HTML] Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002‒2011
B Karo, B Hauer, V Hollo, MJ van der Werf… - …, 2015 - eurosurveillance.org
Monitoring the treatment outcome (TO) of tuberculosis (TB) is essential to evaluate the
effectiveness of the intervention and to identify potential barriers for TB control. The global …
effectiveness of the intervention and to identify potential barriers for TB control. The global …
[HTML][HTML] Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
B Karo, W Haas, C Kollan… - BMC infectious …, 2014 - Springer
Background Tuberculosis (TB) still presents a leading cause of morbidity and mortality
among people living with HIV/AIDS (PLWHA), including those on antiretroviral therapy. In …
among people living with HIV/AIDS (PLWHA), including those on antiretroviral therapy. In …
Increasingly limited options for the treatment of enteric fever in travellers returning to England, 2014–2019: a cross-sectional analytical study
MT Herdman, B Karo, J Dave… - Journal of Medical …, 2021 - microbiologyresearch.org
Introduction. Enteric fever (caused by Salmonella enterica serovars Typhi and Paratyphi)
frequently presents as an acute, undifferentiated febrile illness in returning travellers …
frequently presents as an acute, undifferentiated febrile illness in returning travellers …
Clinical management and impact of scarlet fever in the modern era: findings from a cross-sectional study of cases in London, 2018–2019
Objectives In response to increasing incidence of scarlet fever and wider outbreaks of group
A streptococcal infections in London, we aimed to characterise the epidemiology, symptoms …
A streptococcal infections in London, we aimed to characterise the epidemiology, symptoms …
VirA+ EmiC project: Evaluating real‐world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency …
G Nebbia, M Ruf, L Hunter… - Journal of Viral …, 2022 - Wiley Online Library
Innovative testing approaches and care pathways are required to meet global hepatitis B
virus (HBV) and hepatitis C virus (HCV) elimination goals. Routine blood‐borne virus (BBV) …
virus (HBV) and hepatitis C virus (HCV) elimination goals. Routine blood‐borne virus (BBV) …